Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Global Influenza Diagnostics Market: By Type: Traditional Diagnostic Test, Molecular Diagnostic Assay; By End Use: Hospital, Research Laboratory, Others; Regional Analysis; Historical Market and Forecast (2016-2026); SWOT Analysis; Competitive Landscape; Industry Events and Developments
Global Influenza Diagnostics Market Outlook
The global influenza diagnostics market attained a value of USD 657 million in 2020. The influenza diagnostics market is further expected to grow in the forecast period of 2021-2026 at a CAGR of 9% to reach USD 1103.3 million by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The influenza diagnostics market is being driven by the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of influenza.
Properties and Applications
Influenza diagnostics help determine if a person is suffering from influenza by detecting the influenza viral nucleoprotein antigen. These are commercially available and help provide results in as less as 30 minutes span, exhibiting colour change or other visual signals.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The global influenza diagnostics market is segmented into types and end-uses.
The industry can be broadly categorised based on its types as:
- Traditional Diagnostic Test
- Molecular Diagnostic Assay
The traditional diagnostic test is further divided into rapid influenza diagnostic test (RIDT), viral culture, direct fluorescent antibody (DFA) test, and serological assay. The molecular diagnostic assay is subdivided into reverse transcription polymerase chain reaction (RT-PCR), nucleic acid sequence-based amplification (NASBA) test, loop-mediated isothermal amplification-based assay (LAMP), simple amplification-based assay (SAMBA), and other molecular diagnostic assays.
The industry can be divided based on its end-use into:
- Hospital
- Research Laboratory
- Others
The EMR report looks into the regional influenza diagnostics markets like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
The influenza diagnostics market is being driven by the rising prevalence of influenza over the forecast period. The growing awareness among the population about the early diagnosis and effective treatment of influenza is aiding the market growth. It is also recommended for all patients with suspected influenza, thus, further enhancing the influenza diagnostics industry. The influenza diagnostics market is positively influenced by the rising funding for influenza diagnosis, research, and treatment. The disease can further degrade the health and develop complications in an individual, like pneumonia, bronchitis, asthma flare-ups, heart problems, and an ear infection, among others, creating an immediate need for influenza diagnostic and treatments, further propelling the influenza diagnostics market forward.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global influenza diagnostics market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- Abbott [NYSE: ABT]
- Becton, Dickinson and Company
- Coris BioConcept
- DiaSorin SpA
- F. Hoffmann-La Roche Ltd.
- Luminex Corporation
- Meridian Bioscience Inc.
- Quidel Corporation
- Sekisui Diagnostics
- Thermo Fisher Scientific Inc.
- Others
The EMR report gives an in-depth insight into the influenza diagnostics market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2016-2020 |
| Forecast Period | 2021-2026 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Type, End Use, Region |
| Breakup by Type | Traditional Diagnostic Test, Molecular Diagnostic Assay |
| Breakup by End Use | Hospital, Research Laboratory, Others |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, EMR’s Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Abbott [ABT (NYSE)], Becton, Dickinson and Company [BDX (NYSE)], Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd. [ROG (SWX)], Luminex Corporation [LMNX (NASDAQ)], Meridian Bioscience Inc. [VIVO (NASDAQ)], Quidel Corporation [QDEL (NASDAQ)], Sekisui Diagnostics, Thermo Fisher Scientific Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
1.1 Objectives of the Study
1.2 Key findings of the Study
2 Research Methodology
2.1 Data Extraction
2.2 Data Corroboration
2.3 Market Structure
2.4 Inference Data
3 Executive Summary
3.1 Market Overview
3.2 Market Analysis
4 Global Influenza Diagnostics Market Analysis
4.1 Global Influenza Diagnostics Historical Market (2016-2020) & Forecast (2021-2026)
4.2 Global Influenza Diagnostics Market Breakup by Type
4.2.1 Traditional Diagnostic Test
4.2.1.1 Rapid Influenza Diagnostic Test (RIDT)
4.2.1.2 Viral Culture
4.2.1.3 Direct Fluorescent Antibody (DFA) Test
4.2.1.4 Serological Assay
4.2.2 Molecular Diagnostic Assay
4.2.2.1 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
4.2.2.2 Nucleic Acid Sequence-Based Amplification (NASBA) Test
4.2.2.3 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
4.2.2.4 Simple Amplification-Based Assay (SAMBA)
4.2.2.5 Other Molecular Diagnostic Assays
4.3 Global Influenza Diagnostics Market Breakup by Type: Historical Market (2016-2020) & Forecast (2021-2026)
4.3.1 Traditional Diagnostic Test
4.3.1.1 Rapid Influenza Diagnostic Test (RIDT)
4.3.1.2 Viral Culture
4.3.1.3 Direct Fluorescent Antibody (DFA) Test
4.3.1.4 Serological Assay
4.3.2 Molecular Diagnostic Assay
4.3.2.1 Reverse Transcription-Polymerase Chain Reaction (RT-PCR)
4.3.2.2 Nucleic Acid Sequence-Based Amplification (NASBA) Test
4.3.2.3 Loop-Mediated Isothermal Amplification-Based Assay (LAMP)
4.3.2.4 Simple Amplification-Based Assay (SAMBA)
4.3.2.5 Other Molecular Diagnostic Assays
4.4 Global Influenza Diagnostics Market Breakup by End Use
4.4.1 Hospital
4.4.2 Research Laboratory
4.4.3 Others
4.5 Global Influenza Diagnostics Market Breakup by End Use: Historical Market (2016-2020) & Forecast (2021-2026)
4.5.1 Hospital
4.5.2 Research Laboratory
4.5.3 Others
4.6 Global Influenza Diagnostics Market Breakup by Region
4.6.1 North America
4.6.1.1 United States of America
4.6.1.2 Canada
4.6.2 Europe
4.6.2.1 Germany
4.6.2.2 United Kingdom
4.6.2.3 France
4.6.2.4 Italy
4.6.2.5 Others
4.6.3 Asia Pacific
4.6.3.1 China
4.6.3.2 Japan
4.6.3.3 India
4.6.3.4 ASEAN
4.6.3.5 Others
4.6.4 Latin America
4.6.4.1 Brazil
4.6.4.2 Argentina
4.6.4.3 Mexico
4.6.4.4 Others
4.6.5 Middle East & Africa
4.6.5.1 Saudi Arabia
4.6.5.2 United Arab Emirates
4.6.5.3 Nigeria
4.6.5.4 South Africa
4.6.5.5 Others
4.7 Global Influenza Diagnostics Market Breakup by Region: Historical Market (2016-2020) & Forecast (2021-2026)
4.7.1 North America
4.7.1.1 United States of America
4.7.1.2 Canada
4.7.2 Europe
4.7.2.1 Germany
4.7.2.2 United Kingdom
4.7.2.3 France
4.7.2.4 Italy
4.7.2.5 Others
4.7.3 Asia Pacific
4.7.3.1 China
4.7.3.2 Japan
4.7.3.3 India
4.7.3.4 ASEAN
4.7.3.5 Others
4.7.4 Latin America
4.7.4.1 Brazil
4.7.4.2 Argentina
4.7.4.3 Mexico
4.7.4.4 Others
4.7.5 Middle East & Africa
4.7.5.1 Saudi Arabia
4.7.5.2 United Arab Emirates
4.7.5.3 Nigeria
4.7.5.4 South Africa
4.7.5.5 Others
5 SWOT Analysis
5.1 Overview
5.2 Strengths
5.3 Weaknesses
5.4 Opportunities
5.5 Threats
6 Porter’s Five Forces Analysis
6.1 Overview
6.2 Buyer’s Power
6.3 Supplier’s Power
6.4 New Entrants
6.5 Degree of Rivalry
6.6 Substitutes
7 EMR’s Key Indicators for Demand
8 EMR’s Key Indicators for Price
9 Key Players & Company Profiles
9.1 Abbott [ABT (NYSE)]
9.1.1 Company Overview
9.1.2 Financial Analysis
9.2 Becton, Dickinson and Company [BDX (NYSE)]
9.2.1 Company Overview
9.2.2 Financial Analysis
9.3 Coris BioConcept
9.3.1 Company Overview
9.3.2 Financial Analysis
9.4 DiaSorin SpA
9.4.1 Company Overview
9.4.2 Financial Analysis
9.5 F. Hoffmann-La Roche Ltd. [ROG (SWX)]
9.5.1 Company Overview
9.5.2 Financial Analysis
9.6 Luminex Corporation [LMNX (NASDAQ)]
9.6.1 Company Overview
9.6.2 Financial Analysis
9.7 Meridian Bioscience Inc. [VIVO (NASDAQ)]
9.7.1 Company Overview
9.7.2 Financial Analysis
9.8 Quidel Corporation [QDEL (NASDAQ)]
9.8.1 Company Overview
9.8.2 Financial Analysis
9.9 Sekisui Diagnostics
9.9.1 Company Overview
9.9.2 Financial Analysis
9.10 Thermo Fisher Scientific Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.11 Others
10 Industry Events and Developments
Key Questions Answered in the Report
In 2020, the global influenza diagnostics market attained a value of nearly USD 657 million.
The market is projected to grow at a CAGR of 9% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2021-2026 to reach about USD 1103.3 million by 2026.
The major drivers of the industry, such as the accelerating prevalence of influenza, the rise in research funding for influenza diagnostics, and the increasing demand for faster diagnosis and management of the disease, are expected to aid the market growth.
The key market trend guiding the industry growth includes the rising funding for influenza diagnosis, research, and treatment.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Traditional diagnostic test and molecular diagnostic assay are the leading types of influenza diagnostics in the industry.
Hospital and research laboratory, among others, are the major end use segments of influenza diagnostics in the market.
The major players in the industry are Abbott, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, and Thermo Fisher Scientific Inc., among others.
Analyst Review
The global influenza diagnostics market attained a value of USD 657 million in 2020, driven by the rising prevalence of influenza. Aided by the rise in research funding for influenza diagnostics, the market is expected to witness a further growth in the forecast period of 2021-2026, growing at a CAGR of 9%. The industry is projected to reach USD 1103.3 million by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the industry can be segmented into traditional diagnostic test and molecular diagnostic assay. On the basis of end uses, the industry can be divided into hospital, research laboratory, and others. The major regional markets for influenza diagnostics are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Abbott, Becton, Dickinson and Company, Coris BioConcept, DiaSorin SpA, F. Hoffmann-La Roche Ltd., Luminex Corporation, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, Thermo Fisher Scientific Inc., and others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The global liquid biopsy market stood at a value of around USD 1,250 million in 2020. The market is further expected to grow at a CAGR of 22% in the forecast period of 2021-2026 to attain a value of U...
The global mammography market attained a value of USD 1.85 billion in 2020, driven by the rising healthcare expenditures, a thriving healthcare market, and the demand for routine screening.
The North America COVID-19 diagnostics market is primarily being driven by the high number of COVID-19 positive cases, especially in the United States of America, which performed about 390 million tes...
The global COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in the United States of America, which had performed about 390 million tests for COVID-19 as of March ...
The Asia Pacific COVID-19 diagnostics market is being aided by the growing cases of COVID-19 infections in India and China, which have performed around 234 million and 160 million tests, respectively,...
NEWSLETTER